We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Medcura Receives Breakthrough Device Designation for LifeGel to Manage Surgical Bleeding
Medcura Receives Breakthrough Device Designation for LifeGel to Manage Surgical Bleeding
Maryland-based Medcura announced that the FDA has granted the company’s LifeGel absorbable surgical hemostatic gel Breakthrough Device designation as a hemostatic agent to control bleeding during surgical procedures.